
News from dpiresearch.com
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top dpiresearch.com News

Johnson & Johnson · United StatesPhase 1b study suggests a promising safety profile and highlights the potential of a novel dual-targeting CD19/CD20 CAR T in patients with relapsed or refractory diseaseSee the Story
Johnson & Johnson's Dual-Targeting CAR T-Cell Therapy Shows Encouraging First Results in Large B-Cell Lymphoma
56% Center coverage: 9 sources

United States · United StatesExplore the growth and future outlook of the United States insulin pen market, valued at approximately $3 billion in 2023 and projected to reach $5.5 billion by 2033. Discover key drivers such as technological advancements, increased awareness in diabetes management, and favorable reimbursement policies. Learn about market segmentation, including smart, reusable, and disposable insulin pens, and the competitive landscape featuring major players.…Read Article